Cormorant Private Healthcare Fund III LP

10% OwnerAmbrx Biopharma Inc. (AMAM) · full profile →Form 4 · filed Apr 17, 2023
Net Buying
Open-Market Buys
$25.3M
Open-Market Sells
$0
Net Open-Market Flow
$25.3M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 17, 2023Buy(P)562K$10.67$6.0M62.1M
Apr 14, 2023Buy(P)842K$9.96$8.4M61.5M
Apr 13, 2023Buy(P)1.2M$9.16$10.9M60.7M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000929638-23-001185) within minutes of acceptance. Every field above traces to the original document. Verify it directly: